PRP therapy in cardiac surgery
Platelet Rich Plasma (PRP) has been the focus of treatment for athletes in recent years to treat sports injuries. However, not many people know that it was first used in open heart surgery. Or that doctors first developed this treatment as a medical method for dentistry. About 50 years later, cardiac surgeons performing the most innovative heart procedures continue to use PRP treatment in heart surgery.
With the discovery of PRP therapy, doctors discovered that they could use platelets from the patient's own blood. This allowed them to heal the surgical incision faster. Also reduces the risk of infections like Deep Sternum Wound Infections (DSWI). Using PRP could also prevent the patient's body from rejecting the foreign transfusion. In addition, surgeons may use PRP if the vein has been removed for the bypass procedure.
More recently, heart surgeons have used PRP in heart transplants, according to studies by the National Centre for Biotechnology Information. They also add serum when wearing devices that can assist heart functions. As ventricular assist devices (VADs).
Using PRP therapy in cardiac surgery, cardiac surgeons reduced the risk of DSWI from 2.0% to 0.6% and sterile infection from 8.0% to 2.0%. Fewer patients had to be readmitted for post-operative complications. In addition, the cost of treating surgical infections decreased from USD 1,256,960 to USD 593,791.
PRP therapy can not only help patients recover faster, but also reduce the cost of postoperative cardiac care.